'Glycerolipid Metabolism' were used. In addition, the family of carboxylesterase (Ces) genes were 1 3 9 analysed due to their recently discovered role in triglyceride hydrolysis [19] [20] [21] . Finally, to dissect the 1 4 0 link between lipid metabolism and one carbon metabolism, relevant mediators were analysed and 1 4 1 mapped to known biochemical pathways. 1B). MCDD liver weights were lower in MCDD fed mice but not CDD ( Figure 1C ). Histological 1 7 2 analysis revealed severe hepatic steatosis in both groups ( Figure 1D ) with a significant increase in 1 7 3 hepatic fibrosis in the MCDD group ( Figure 1E ). Next we carried out analysis of the transcriptome in control, CCD or MCDD mouse livers, each n=4. This approach allowed us to interrogate ~18,000 transcripts per mouse liver and analysis of total 1 7 8 datasets revealed a number of transcriptional differences between animals. Unsupervised clustering of 1 7 9 the 500 most variable transcripts between all animals was sufficient to cluster into the different dietary 1 8 0 interventions (Figure 2A ). Both interventions induced a >1.5-fold differential expression in multiple Tables 3 and 4 . Of the 234 genes differentially expressed in CDD, 194 (82.4%) were also 1 8 4 differentially expressed in MCDD. The additional restriction of methioine over and above choline 1 8 5 induced the differential expression of a further 1032 transcripts ( Figure 2B ). Transcripts showing at least a 2-fold change were segregated into up-regulated and down-regulated GO-terms for lipid, sterol, fatty acid and organic acid biosynthesis were markedly over-represented in 1 9 0 the list of suppressed genes. Over-expressed pathways in CDD mice included 'immune system 1 9 1 process' and 'inflammatory response'. Up-regulated pathways in mice on the MCDD diet included The most up-regulated genes in CDD mice included immune mediators (Gpnmb, Ly6d); fibrosis 1 9 6 mediators (Mmp12, Mmp13); and the detoxification enzymes Gsta1 and Gsta2 and the microsomal 1 9 7 enzyme Cyp4a14. The most suppressed genes in CDD included lipid synthesis genes (Sqle, Elovl3,
Elovl6, Aacs, Acly, Acss2, Acacb), the endopeptidase inhibitor Serpina4-ps1 and the multifunctional 1 9 9 triglyceride metabolism enzyme Pnpla3. Whilst these genes were similarly differentially expressed in metalloproteinase Adam32, the inflammatory mediator Slpi and the aldo-ketoreductase Akrb7. We then proceeded to examine pathways of lipid uptake, synthesis and disposal. Differentially changes were generally greater in MCDD than CDD although they occurred in the same direction. Previous studies have suggested an increase in lipid uptake with MCDD, with upregulation of some of 2 1 7 the FATP/solute carrier family 27 genes in association with increased sequestration of isotope labelled 2 1 8 fatty acids 17,26 , however we noted only the down-regulation of the fatty acid translocase Scla27a5 2 1 9 (FATP5) with no change in the other FATP isoforms. We did identify marked upregulation of 2 2 0 1 0 lipoprotein lipase, a key mediator in triglyceride hydrolysis from lipoproteins. In keeping with the 2 2 1 gene ontology analysis, the global picture suggests suppressed hepatic lipid synthesis. Perturbed genes 2 2 2 in pathways of fatty acid biosynthesis initiation, Acyl-CoA synthesis, fatty acid elongation and 2 2 3 cholesterol synthesis were almost universally down-regulated. We then examined dominant pathways of hepatic fatty acid fate (triglyceride synthesis, β -oxidation, 2 2 6 oxidation and peroxisomal oxidation). These were found to be relatively unaffected, apart from an Interestingly, isoforms of Cyp4a enzymes demonstrated marked bi-directional differential expression 2 3 2 with Cyp4a12a and Cyp4a12b strongly suppressed in CDD and MCDD whilst Cyp4a14 was Cyp4a32, Cyp4a29, Cyp4a30b) were unchanged. Cyp2e, which has previously been reported to be 2 3 5 upregulated in MCDD was also unchanged 29 . In keeping with the theory of impaired very-low- insulin signal transduction (Irs2 and Pdk1) were also down-regulated. Given the importance of choline and methionine as methyl donors, we then proceeded to examine the 2 4 6 expression of genes important in one-carbon metabolism. There were striking changes in the 2 4 7 expression of genes associated with choline, methionine and phosphatidylcholine (PC) metabolism in It is widely assumed that the steatosis induced by CDD and MCDD results from impaired export of 3 0 4
VLDLs, which are required for triglyceride clearance from hepatocytes, perhaps because deficiency 3 0 5 of choline and methionine results in an inability to synthesise the major lipid bilayer component 3 0 6
phosphatidylcholine (PC) required for VLDL synthesis 30, 34 . Our study supports the concept that both 3 0 7
decreased PC synthesis and impaired VLDL secretion may play a role in the hepatic pathology in 3 0 8
these models and suggest a potential role for the carboxylesterase (Ces) enzymes in mediating the 3 0 9
reduction in VLDL secretion.
The importance of reduced hepatic lipid clearance in MCDD is supported by studies demonstrating i) incorporation of 14 C into hepatic triglycerides suggest that increased lipid uptake and/or increased de 3 1 6
novo lipogenesis may also occur with MCDD 17,26,34 . These effects have not been reported in rodents 3 1 7
exposed to CDD alone 17, 35 ; indeed ex vivo studies using primary hepatocytes isolated from rats 3 1 8
maintained on CDD has shown that the presence of methionine is sufficient to maintain normal levels apolipoprotein secretion in choline deficient media 9 . These findings may be due to the presence of an ~30% of PC is synthesised in this way in rodent liver 36 . In our study, detailed analysis of the expression of genes in de novo lipogenesis pathways in CDD and 3 2 7
MCDD strongly suggest an appropriate compensatory response to the high hepatic triglyceride cholesterol synthesis (Figure 7) . This supports the concept that impaired lipid clearance rather than 3 3 0 impaired de novo lipogenesis is responsible for the hepatic fat accumulation that occurs with both specific knock-down results in increased hepatic triglyceride 19 . Whilst it is unclear why the 3 4 0 expression of these genes is suppressed in the presence of an increased hepatic lipid load (notably in 3 4 1 MCDD), we suggest that these models may present an opportunity for investigating the mechanism of 3 4 2 action of these important hepatic lipid clearance enzymes and the screening of therapeutics that reported to have ~73% more hepatic triglyceride when compared with matched heterozygote controls, 3 4 7
and both in vivo and in vitro studies suggest that this is due to impaired triglyceride hydrolysis and 3 4 8
VLDL export [39] [40] [41] [42] . Thus, Pnpla3 suppression may also contribute to triglyceride accumulation in 3 4 9 methyl donor deficiency.
3 5 0
Dissection of the interacting pathways involved in choline, methionine and PC metabolism in these 3 5 1 models provides further insights into the mechanisms by which the murine liver responds to dietary the essential amino acid methionine is also necessary for the methylation of a large variety of 3 5 4
substrates including DNA, proteins and lipids and for the synthesis of polyamines, and it is also an inflammatory steatohepatitis with fibrogenesis and significant weight loss with an increase in 3 7 6 peripheral insulin sensitivity 30, 52 . Our transcriptomic analysis also suggests that CDD and MCDD 3 7 7 produce a hepatic phenotype which is markedly dissimilar to human NAFLD in terms of lipid 3 7 8
handling. Whereas human NAFLD is associated with an upregulation of genes important in de novo depletion is a feature of human NAFLD and correlates with severity of disease in NAFLD biopsies, (logFC -0.97)), however these did not reflect the changes seen in the mouse model apart from a 3 9 0 similar change in the expression of GNMT. In conclusion, our data suggest a novel alternative mechanism for methyl donor deficient liver injury 3 9 3
involving impaired VLDL particle assembly due to suppression of key triglyceride hydrolysis 3 9 4
proteins. Although these CDD and MCDD models are widely used for the study of NAFLD, their 3 9 5
translational impact in studies of NAFLD/NASH is likely to be limited by fundamental differences in 3 9 6 the global transcriptional profiles between these models and human disease states. Our data do 3 9 7
suggest that MCDD may be a useful model for studying the development of HCC secondary to the 3 9 8 premalignant inflammatory steatohepatitis NASH. We suggest that there remains an urgent need for 3 9 9
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